Created in 2018 by BTL Industries, the Emsella chair is already revolutionising common intimate issues for men and women in as little as six, 28-minute sessions
One in seven adults experience incontinence, with statistics rising to almost one in three in older age groups. The Emsella chair can benefit anyone suffering from urinary incontinence – those who developed stress incontinence following childbirth and also women who are going through perimenopause. But it doesn’t just affect women. Men, particularly those treated for prostate cancer, can also suffer from pelvic floor disorders but are typically less likely to seek treatment.
So it was a huge breakthrough when, in 2018, BTL introduced the Emsella. This double FDA-approved medical device is proven and rigorously tested to support the recovery of incontinence and the function of intimate health. The system was developed through years of research and development (R&D) supported by BTL’s clinically-led physiotherapy department, head quartered in the Czech Republic Prague, where BTL have one of the largest medical device equipment research centres globally.
The BTL EMSELLA treatment uses High-Intensity Focused Electro Magnetic Energy (HIFEM) to stimulate and strengthen all the pelvic floor muscles, not just the subset that can be exercised with voluntary contractions (Kegel exercises). These stronger pelvic floor muscles restore continence and the confidence to enjoy regular daily activities without fear of losing bladder control.
Typically, six sessions of 28 minutes are necessary (sometimes it may require more). During each session, you sit comfortably on the Emsella chair while it generates thousands of supramaximal pelvic floor muscle contractions. Each session is equivalent to doing 11,000 pelvic floor exercises without the hard work. The procedure is non-invasive, and you remain fully clothed throughout. You will most likely feel a slight tingling during the treatment. You can leave immediately after each session with no recovery time and resume normal daily activity.
“It makes complete sense that by strengthening the pelvic floor, we can strengthen and rehabilitate the vaginal wall. Stimulating the nerve endings within the walls of the vagina itself, leading to significantly increased sensation during intercourse,” Dee MacMahon, Managing Director of BTL Industries for Ireland and Northern Ireland, says. “This is a magnificent therapy for many potential patients who can enhance their intimate lives.”
And the success rates are incredibly impressive, with 95 per cent of treated patients reporting significant improvement in their quality of life, a game-changer in incontinence, sexual wellness and general gynaecological and prostate health.
BTL Ireland proudly has an affiliate office based in Dublin with a dedicated clinical training team, sales and engineering and client success managers. To enquire about a device or any information on BTL systems, contact medicalIreland@btlnet.com
